Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients- a Double Blind Placebo Controlled Randomized Trial

NCT04884490 is registered in ClinicalTrials.gov with Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh as lead sponsor.

NCT NCT04884490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04884490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients- a Double Blind Placebo Controlled Randomized Trial
Lead sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase
Phase 2/3
Overall status
Completed
Start date
May 15, 2021
Completion date
November 14, 2021
Enrollment
94 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia